Table 1 Characteristics of patients exhibiting lung adverse events related to nivolumab.
From: Evaluation of lung adverse events with nivolumab using the spontaneous reporting system in Japan
Variable | Value (%) |
|---|---|
Number of patients | 3,084 |
Sex | |
Male | 2,416 (78.3) |
Female | 623 (20.2) |
Unknown | 45 (1.5) |
Age (years) | |
≤ 10 s | 1 (0.03) |
20 s | 6 (0.2) |
30 s | 20 (0.6) |
40 s | 121 (3.9) |
50 s | 354 (11.5) |
60 s | 1,079 (35.0) |
70 s | 1,161 (37.6) |
80 s | 250 (8.1) |
90 s | 3 (0.1) |
Unknown | 89 (2.9) |
